Found 3 articles for: "Glabellar Lines"
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines
October 2021 | Volume 20 | Issue 10 | Original Article | 1052 | Copyright © October 2021
Background: To further explore clinical trial results indicating increasing doses of botulinum toxin A prolong duration of effect, a 2-stage, phase 2, randomized, double-blind study i...
Read MoreAbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data
September 2021 | Volume 20 | Issue 9 | Original Article | 988 | Copyright © September 2021
Background: Increasing the reconstitution and injection volumes of abobotulinumtoxinA (aboBoNT-A) could provide more options for aesthetic healthcare professionals.
Obje...
Read MoreAbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study
September 2021 | Volume 20 | Issue 9 | Original Article | 980 | Copyright © September 2021
Objective: To evaluate the efficacy and safety of AbobotulinumtoxinA (ABO) dose escalation in the correction of moderate-to-severe glabellar lines.
Design: Phas...
Read More
